维普中文期刊产品整合服务
25篇 您的检索式:作者名="Zengin B"
    题名 作者 年代 出处 被引量
1Role of inferior vena cava and right ventricular diameter in assessment of volume status:a co- mparative study:ultrasound and hypovolemia显示文摘Zengin S A1 B Gene S 2013The American journal of emergency medicine2013,31,:1
2An assessment of oxidant/antioxi- dant status in patients with snake envenomatian显示文摘Zengin S AI B Yarbil P 2014Emerg Med J2014,31,1:1
3Perceptions of pre-service teachers of English towards grammar teaching in the Turkish context 显示文摘Kaqar I Zengin B 2013The Journal of Language and Linguistic Studies2013,,3:1
4Role of inferior vena cava and right ventricular diameter in assessment of volume status : a comparative study: ultrasound and hypow~lemia显示文摘Zengin S AI B Gene S 2013Am J Emerg Med2013,31,:1
5Surface modifi-cation of glass beads with poly(acrylic acid)显示文摘Zengin H Hu B Siddiqui J A 2006Poly-mers for Advanced Technologies2006,17,5:1
6Thermomechanical and thermogravimetric analysis of blends of poly (vinyl chloride) with maleic anhydride-allyl propionate copolymer显示文摘Boztug A Zengin H B Basan S 2004Journal of Molecular Structure2004,697,1:1
7Role of inferior vena cava and right ventricular diameter in assessment of volume status: a comparative study: ultrasound and hypovolemia 显示文摘Zengin S A1 B Gene S 2013Am J Emerg Med2013,31,5:1
8Role of inferior vena ca- va and right ventricular diameter in assessment of volume status: a comparative study: ultrasound and hypovolemia 显示文摘Zengin S A1 B Genc S 2013Am J Emerg Med2013,31,5:1
9Effects of music therapy on pain and anxiety in patients undergoing port catheter place- ment procedure显示文摘Zengin S Kabul S A1 B 2013Complementary Therapies in Medicine2013,21,6:1
10Role of inferior vena cava and fight ventrieular diameter in assessment of volume status: a comparative study: ultrasound and hypovolemia显示文摘Zengin S A1 B Gene S 2013Am J Emerg Med2013,31,5:1
11Therapeutic red cell exchange for severe carbon monoxide poisoning显示文摘Zengin S Y?lmaz M Al B 0,,:1
12Evaluation of retinal nerve fiber layer thickness in patients with anisometropic and stra- bismic amblyopia using optical coherence tomography显示文摘Ersan I Zengin N Bozkurt B 2013J Pediatr Ophthalmol Strabismus2013,50,2:1
13Effects of music therapy on pain and anxiety in patients undergoing portcatheter placement procedure 显示文摘Zengin S Kabul S AI B 2013Complement Ther Med2013,21,:1
14Interobserver and Intraobserver Agreement ofSongraphic BIRADS Lexicon in the Aseessment of Breast Masses显示文摘Elverici E Zengin B Barca AN 2013Iran JRadiol2013,10,3:1
15IRF6 is in- volved in the regulation of cell proliferation and transformation in MCF10A cells downstream of Notch signaling显示文摘Zengin T Ekinci B Kucukkose C Yalcin - Ozuysal O 2015PLoS One2015,10,01:1
16Adsorption of acids and bases from aqueous solutions onlo silicon dioxide particles显示文摘Zengin H Erkan B 2009Hazard Mater2009,172,23:1
17Interobserver and Intraobserver Agreement of Sonographic BIRADS Lexicon in the Assessment of Breast Masses显示文摘Elverlci E Zengin B Barca AN 2013Iran J Radiol2013,10,3:1
18Interobserver and intraobserver agreement of sonographic BIRADS lexicon in the assessment of breast masses显示文摘Elverici E Zengin B Nurdan Barca A 2013Iran J Radiol2013,10,3:1
19lasma exchange as a complementary approach to snake bite treatment: an academic emergency depart- ment's experiences显示文摘Zengin S Yilmaz M AI B 2013Transfus Apher Sci2013,49,3:1
20Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?显示文摘Gastrointestinal stromal tumors(GISTs) are the most common soft tissue sarcoma of the gastrointestinal tract,resulting from an activating mutation of stem cell factor receptor(KIT),and an activating mutation of the homologous platelet-derived growth factor receptor alpha(PDGFRA) kinase.Most GISTs(90%-95%) are KIT-positive.About 5% of GISTs are truly negative for KIT expression.GISTs have been documented to resistant conventional chemotherapeutics.Due to the KIT activation that occurs in the majority of the cases,KIT inhibition is the primary treatment approach in the adjuvant treatment of metastatic GISTs.Imatinib mesylate is an oral agent that is a selective protein tyrosine kinase inhibitor of the KIT protein tyrosine kinase,and it has demonstrated clinical benefit and objective tumor responses in most GIST patients in phase Ⅱ and Ⅲ trials.The presence and the type of KIT or PDGFRA mutation are predictive of response to imatinib therapy in patients with advanced and metastatic disease.Molecular analysis in phaseⅠ-Ⅱ trials revealed significant differences in objective response,progression-free survival,and overall survival between GISTs with different kinase mutations.The aim of this letter is to touch on the need for exon mutation analysis for adjuvant treatment with imatinib in GIST patients.Mehmet Ali Nahit Sendur Nuriye Yildirim zdemir Muhammed Bülent Akinci Dogan Uncu Nurullah Zengin Sercan Aksoy 2013World Journal of Gastroenterology2013,19,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费